About TSRI
Research & Faculty
News & Publications
Scientific Calendars
Scripps Florida
PhD Program
Campus Services
Work at TSRI
TSRI in the Community
Giving to TSRI
Directory
Library
Contact
Site Map & Search
TSRI Home

Scientific Report 2004


Molecular and Experimental Medicine



Division of Rheumatology Research



Impact of Innate Immunity in Allergy and Infectious Diseases


B.L. Zuraw, S.C. Christiansen, J. Eddleston, A. Kiemer, S. Mattsson

Inflammation plays a critical role in the pathogenesis of many allergic and infectious diseases. We focus on how components of the innate immune system modulate inflammatory responses and influence the course of several allergic and infectious diseases.

Airway Epithelial Cells and Asthmatic Inflammation

Delineation of the parameters that control the initiation and propagation of airway inflammation may provide new therapeutic targets for the treatment of asthma. Using in vitro and in vivo challenge models, we are studying the short-term consequences of exposure to allergens and viruses on activation of transcription factors and expression of genes in human airway epithelial cells. Glucocorticoid-induced leucine zipper interferes with activation of the transcription factors NF-κB and activator protein 1 in myeloid cells. We have shown that glucocorticoid-induced leucine zipper is expressed in airway epithelial cells, and we are studying how it participates in airway inflammation, particularly after rhinovirus infection.

In recent studies, we found that a variety of soluble mediators generated in the airway, including kinins and cytokines, can activate SMADs in airway epithelial cells. SMADs are transcription factors involved in airway remodeling; they stimulate collagen synthesis in part by increasing expression of connective tissue growth factor (CTGF). We found a corresponding rapid increase in CTGF mRNA and protein in stimulated airway epithelial cells. We are addressing the effects of airway epithelial cell CTGF on activation of lung fibroblasts and production of collagen.

C1 Inhibitor Mutations in Hereditary Angioedema

Hereditary angioedema is an autosomal dominant disease caused by a mutation of the gene for C1 inhibitor and characterized by recurrent angioedema. Bradykinin, a mediator of the effector arm of the innate immune system, is a potent mediator of increased vascular permeability. Our studies have implicated activation of the plasma contact system with subsequent generation of bradykinin as the causal factor in angioedema associated with deficiency in C1 inhibitor. We identified a variety of new mutations and polymorphisms of the gene for C1 inhibitor in patients with hereditary angioedema, and we are characterizing the transcriptional and posttranscriptional control of mutant and wild-type C1 inhibitor expression to define the genotype-phenotype relationships in this disease. Currently, we are focusing on interventions that may increase the synthesis and secretion of functional C1 inhibitor in patients with hereditary angioedema, changes that might decrease the severity of the disease in these patients.

Activation of Alveolar Macrophages and the Outcome of Infection

Alveolar macrophages are exploited by several important human pathogens, including Mycobacterium tuberculosis and Bacillus anthracis endospores. We are studying the interactions between these microorganisms and human macrophages. Alveolar macrophages play a critical role in the pathogenesis of inhalational anthrax, phagocytosing B anthracis endospores and transporting them to the mediastinal lymph nodes where the spores germinate and release toxins. We are assessing the efficiency of killing of ingested B anthracis endospores by alveolar macrophage to elucidate environmental and genetic factors that may determine whether the spores survive and lead to outgrowth of B anthracis.

We are also interested in how the innate response of alveolar macrophages influences the pathogenesis of tuberculosis. Morbidity and mortality in patients with tuberculosis are due to the ability of M tuberculosis to establish prolonged infection of macrophages. We propose that the intensity of the macrophage response to M tuberculosis may determine whether the infection becomes chronic, and we are focusing on the ability of mycobacterial DNA to activate macrophages through signaling via Toll-like receptor 9.

In collaboration with H. Herwald, Lund University, Lund, Sweden, we showed that Staphylococcus aureus proteins activate blood monocytes and induce B1 receptors for bradykinin in bystander cells. Kinins, generated in plasma by S aureus proteins, enhance the expression of B1 receptors. In ongoing experiments, we are examining how these effects may contribute to the regulation of vascular permeability and shock in patients with systemic infections.

Publications

Chen, L.Y., Zuraw, B.L., Ye, R.D., Pan, Z.K. A Rho exchange factor mediates fMet-Leu-Phe-induced NF-κB activation in human peripheral blood monocytes. J. Biol. Chem. 279:7208, 2004.

Dosanjh, A., Zuraw, B. Endothelin-1 (ET-1) decreases human bronchial epithelial cell migration and proliferation: implications for airway remodeling in asthma. J. Asthma 40:883, 2003.

Stevenson, D.D., Simon, R.A., Zuraw, B.L. Sensitivity to aspirin and nonsteroidal anti-inflammatory drugs. In: Middleton’s Allergy Principles and Practice, 6th ed. Adkinson, N.F., Jr., et al. (Eds.). Mosby, St. Louis, 2003, p. 1695.

Stevenson, D.D., Zuraw, B.L. Pathogenesis of aspirin-exacerbated respiratory disease. Clin. Rev. Allergy Immunol. 24:169, 2003.

Zuraw, B.L. Diagnosis and management of hereditary angioedema: an American approach. Transfus. Apheresis Sci. 29:239, 2003.

Zuraw, B.L. Urticaria and angioedema. In: Pediatric Allergy: Principles and Practice. Leung, D.Y.M., et al., (Eds.). Mosby, St. Louis, 2003, p. 574.

 


Bruce L. Zuraw, M.D.
Associate Professor